Press Releases

Date Title and Summary Additional Formats
Toggle Summary Medidata Schedules Second Quarter Earnings Conference Call for July 18, 2017
NEW YORK --(BUSINESS WIRE)-- Medidata (NASDAQ:MDSO), the leading global provider of cloud-based technology and data analytics for clinical research, today announced that it will release its second quarter 2017 financial results before the open of the market on Tuesday, July 18, 2017 .
View HTML
Toggle Summary Chugai Deploys RaveX to Modernize Post-Marketing Surveillance
Tokyo -based Pharmaceutical Company Expands Use of Medidata's Unified Technology Platform to Simplify Study Navigation, Improve Data Quality and Speed Data Entry Times NEW YORK --(BUSINESS WIRE)-- Medidata (NASDAQ:MDSO), the leading global provider of cloud-based solutions and data analytics for
View HTML
Toggle Summary Theracos More Effectively Manages Both Data and Content with Medidata's eTMF and eTMF Archive Solutions
Medidata's collaboration platform will allow Theracos to seamlessly manage regulated content and actively maintain inspection readiness NEW YORK --(BUSINESS WIRE)-- Medidata (NASDAQ:MDSO), the leading global provider of cloud-based solutions and data analytics for clinical research, today announced
View HTML
Toggle Summary inVentiv Health Selects Medidata Enroll®, Medidata's eConsent Platform, to Accelerate Clinical Trials
inVentiv and Medidata Partner to Expand Use of Patient-Centered Technology to Better Connect Patients, Sites and Biopharmaceutical Clients NEW YORK & BOSTON --(BUSINESS WIRE)-- Medidata (NASDAQ:MDSO), the leading global provider of cloud-based technology and data analytics for clinical research,
View HTML
Toggle Summary Median Technologies and Medidata Partner to Deliver Differentiated Image Management Services in Clinical Trials
France -based Organization to Tap into Medidata Platform to Accelerate the Development of New Medicines in Oncology Medidata Medical Imaging™ Analyzes, Captures and Manages Fastest Growing Data Source in Healthcare Industry NEW YORK & SOPHIA ANTIPOLIS, France --(BUSINESS WIRE)-- Medidata
View HTML
Toggle Summary Sponsors and CROs Rely on Analytics in Clinical Research but Are Limited to Traditional and In-House Data, Medidata Finds
Survey Results Reveal Top Challenges Facing Life Sciences Companies Today, as Well as Emerging Data Sets, Technologies and Trends to Alleviate Hurdles in Drug Development NEW YORK --(BUSINESS WIRE)-- Medidata (NASDAQ:MDSO), the leading global provider of cloud-based technology and data analytics
View HTML
Toggle Summary Chiltern and Medidata Mark 10-Year Anniversary Milestone in Bringing Cloud-based Technology to Clinical Development
WILMINGTON, N.C. & NEW YORK --(BUSINESS WIRE)-- Medidata (NASDAQ:MDSO), the leading global provider of cloud-based technology and data analytics for clinical research, and Chiltern , a leading global contract research organization (CRO), today announced an anniversary milestone in their strategic
View HTML
Toggle Summary UPDATED PRESENTATION DATE: Medidata to Present at Bank of America Merrill Lynch 2017 Global Technology Conference
NEW YORK --(BUSINESS WIRE)-- Medidata (NASDAQ:MDSO), the leading global provider of cloud-based technology and data analytics for clinical research, today announced that Rouven Bergmann , chief financial officer, will present at the Bank of America Merrill Lynch 2017 Global Technology Conference on
View HTML
Toggle Summary Medidata to Present at Bank of America Merrill Lynch 2017 Global Technology Conference
NEW YORK --(BUSINESS WIRE)-- Medidata (NASDAQ:MDSO), the leading global provider of cloud-based technology and data analytics for clinical research, today announced that Rouven Bergmann , chief financial officer, will present at the Bank of America Merrill Lynch 2017 Global Technology Conference on
View HTML
Toggle Summary Medidata to Present First-of-its-kind Scientific Innovation at 2017 ASCO Annual Meeting
NEW YORK --(BUSINESS WIRE)-- Medidata (NASDAQ:MDSO), the leading global provider of cloud-based technology and data analytics for clinical research, today announced its participation in the 2017 American Society of Clinical Oncology (ASCO) Annual Meeting , the premier cancer-focused scientific
View HTML

Investor Contact

Betsy Frank
Head of Investor Relations
+1 917 522 4620
bfrank@mdsol.com

Anthony D'Amico
Senior Director, Investor Relations
+1 732 767 4331
adamico@mdsol.com